Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topoisomerase II{alpha} amplification and anthracycline-based chemotherapy: the jury is still out.

× No keyword cloud information.

6 in total

1. Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: results from North Central Cancer Treatment Group adjuvant trial N9831.

Authors: Alvaro Moreno-Aspitia; David W Hillman; Stephen H Dyar; Kathleen S Tenner; Julie Gralow; Peter A Kaufman; Nancy E Davidson; Jacqueline M Lafky; Monica M Reinholz; Wilma L Lingle; Leila A Kutteh; Walter P Carney; Amylou C Dueck; Edith A Perez
Journal: Cancer Date: 2013-06-06 Impact factor: 6.860

2. Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer.

Authors: Adel Tabchy; Vicente Valero; Tatiana Vidaurre; Ana Lluch; Henry Gomez; Miguel Martin; Yuan Qi; Luis Javier Barajas-Figueroa; Eduardo Souchon; Charles Coutant; Franco D Doimi; Nuhad K Ibrahim; Yun Gong; Gabriel N Hortobagyi; Kenneth R Hess; W Fraser Symmans; Lajos Pusztai
Journal: Clin Cancer Res Date: 2010-09-09 Impact factor: 12.531

Review 3. New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin.

Authors: Iain Rj Macpherson; Tr Jeffry Evans
Journal: Breast Cancer (Dove Med Press) Date: 2009-08-31

4. Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer.

Authors: A Mukherjee; M Shehata; P Moseley; E Rakha; I Ellis; S Chan
Journal: Br J Cancer Date: 2010-11-09 Impact factor: 7.640

5. Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers.

Authors: Pierre-Jean Lamy; Frédéric Fina; Caroline Bascoul-Mollevi; Anne-Claire Laberenne; Pierre-Marie Martin; L'Houcine Ouafik; William Jacot
Journal: Breast Cancer Res Date: 2011-02-02 Impact factor: 6.466

6. Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.

Authors: Pinelopi Gogou; Emilios Pakos; Anna Batistatou; Ioannis Panelos; Evangelos Briasoulis; Dimitrios Stefanou; Nikoforos Apostolikas; Periclis Tsekeris
Journal: World J Surg Oncol Date: 2012-02-02 Impact factor: 2.754

6 in total